Complex adrenergic and inflammatory mechanisms contribute to phase 2 ventricular arrhythmias in anaesthetized rats

British Journal of Pharmacology

Volumn 156, Issue 3, 2009, Pages 444-453

  Clements Jewery, Hugh ^a,b   Andrag, Ellen ^a   Hearse, David J ^a   Curtis, Michael J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

Anaesthesia; Catecholamines; Myocardial infarction; Neutrophil; Phase 2 arrhythmias; Rat; Ventricular fibrillation

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; CATECHOLAMINE; MYELOPEROXIDASE; PRAZOSIN; ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ANESTHESIA; ANIMAL CELL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTERY OCCLUSION; ARTICLE; BLOOD PRESSURE; CELL INTERACTION; CONTINUOUS INFUSION; CORONARY ARTERY LIGATION; DRUG EFFECT; HEART INFARCTION; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; INFLAMMATION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SPRAGUE DAWLEY RAT; ANIMAL; CYTOLOGY; DISEASE MODEL; DRUG COMBINATION; DRUG POTENTIATION; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; IMMUNOLOGY; LEUKOCYTE COUNT; MALE; METABOLISM; PATHOPHYSIOLOGY;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ARRHYTHMIAS, CARDIAC; ATENOLOL; BLOOD PRESSURE; CATECHOLAMINES; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; HEART RATE; LEUKOCYTE COUNT; MALE; NEUTROPHIL INFILTRATION; NEUTROPHILS; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC;

EID: 65449147490     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2008.00054.x     Document Type: Article

References (41)

1. Baker KE, Curtis MJ (2004). Left regional cardiac perfusion in vitro with platelet-activating factor, norepinephrine and K+ reveals that ischaemic arrhythmias are caused by independent effects of endogenous 'mediators' facilitated by interactions, and moderated by paradoxical antagonism. Br J Pharmacol 142 (2 352 366.
2. Benschop RJ, Rodriguez-Feuerhahn M, Schedlowski M (1996). Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav Immun 10 (2 77 91.
3. Botting JH, Johnston KM, Macleod BA, Walker MJ (1983). The effect of modification of sympathetic activity on responses to ligation of a coronary artery in the conscious rat. Br J Pharmacol 79 (1 265 271.
4. Byron JW (1972). Evidence for a ß-adrenergic receptor initiating DNA synthesis in haemopoietic stem cells. Exp Cell Res 71 (1 228 232.
5. Campbell CA, Parratt JR, Kane KA, Bullock G (1984). Effects of prolonged administration of oxprenolol on severity of ischaemic arrhythmias, enzyme leakage, infarct size, and intracellular cardiac muscle action potentials. J Cardiovasc Pharmacol 6 (3 369 377.
6. Clark C, Foreman MI, Kane KA, McDonald FM, Parratt JR (1980). Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J Pharmacol Methods 3 (4 357 368.
7. Clements-Jewery H, Hearse DJ, Curtis MJ (2002a). Independent contribution of catecholamines to arrhythmogenesis during evolving infarction in the isolated rat heart. Br J Pharmacol 135 (3 807 815.
8. Clements-Jewery H, Hearse DJ, Curtis MJ (2002b). The isolated blood-perfused rat heart: an inappropriate model for the study of ischaemia- and infarction-related ventricular fibrillation. Br J Pharmacol 137 (7 1089 1099.
9. Clements-Jewery H, Hearse DJ, Curtis MJ (2005). Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation. Br J Pharmacol 145 (5 551 564.
10. Clements-Jewery H, Hearse DJ, Curtis MJ (2007). Neutrophil ablation with anti-serum does not protect against phase 2 ventricular arrhythmias in anaesthetised rats with myocardial infarction. Cardiovasc Res 73 (4 761 769.
11. Curtis MJ (1998). Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation. Cardiovasc Res 39 (1 194 215.
12. Curtis MJ, Hearse DJ (1989). Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol 21 (1 21 40.
13. Curtis MJ, MacLeod BA, Walker MJ (1984). Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat. Br J Pharmacol 83 (2 373 385.
14. Dynon MK, Jarrott B, Louis WJ (1983). Tissue distribution and hypotensive effect of prazosin in the conscious rat. J Cardiovasc Pharmacol 5 (2 235 239.
15. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES (2000). The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52 (4 595 638.
16. Ferdinandy P, Schulz R, Baxter GF (2007). Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59 (4 418 458.
17. Hamilton CA, Reid JL, Vincent J (1985). Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit. Br J Pharmacol 86 (1 79 87.
18. Harris AS (1950). Delayed development of ventricular ectopic rhythms following experimental coronary occlusion. Circulation 1 : 1318 1328.
19. Harvath L, Robbins JD, Russell AA, Seamon KB (1991). cAMP and human neutrophil chemotaxis. Elevation of cAMP differentially affects chemotactic responsiveness. J Immunol 146 (1 224 232.
20. Jaillon P (1980). Clinical pharmacokinetics of prazosin. Clin Pharmacokinet 5 (4 365 376.
21. Johnston KM, MacLeod BA, Walker MJ (1983). Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics. Can J Physiol Pharmacol 61 (11 1340 1353.
22. Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, Goldberg RJ (1985). Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 312 (4 193 197.
23. Lameris TW, de Zeeuw S, Alberts G, Boomsma F, Duncker DJ, Verdouw PD et al. (2000). Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo. Circulation 101 (22 2645 2650.
24. Lepran I, Koltai M, Siegmund W, Szekeres L (1983). Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats. J Pharmacol Methods 9 (3 219 230.
25. Maestroni GJ, Conti A, Pedrinis E (1992). Effect of adrenergic agents on hematopoiesis after syngeneic bone marrow transplantation in mice. Blood 80 (5 1178 1182.
26. Mainland D, Herrera L, Sutcliffe MI (1956). Statistical Tables for Use with Binomial Samples - Contingency Tests, Confidence Limits and Sample Size Estimates. University College of Medicine Publications : New York.
27. Milmer KE, Clough DP (1983). Optimum ventilation levels for maintenance of normal arterial blood pO2, pC02, and pH in the pithed rat preparation. J Pharmacol Methods 10 (3 185 192.
28. Mullane KM, Read N, Salmon JA, Moncada S (1984). Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther 228 (2 510 522.
29. Mullane KM, Kraemer R, Smith B (1985). Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14 (3 157 167.
30. Nielson CP (1987). Beta-adrenergic modulation of the polymorphonuclear leukocyte respiratory burst is dependent upon the mechanism of cell activation. J Immunol 139 (7 2392 2397.
31. Opitz CF, Mitchell GF, Pfeffer MA, Pfeffer JM (1995). Arrhythmias and death after coronary artery occlusion in the rat. Continuous telemetric ECG monitoring in conscious, untethered rats. Circulation 92 (2 253 261.
32. Pitchford SC, Yano H, Lever R, Riffo-Vasquez Y, Ciferri S, Rose MJ et al. (2003). Platelets are essential for leukocyte recruitment in allergic inflammation. J Allergy Clin Immunol 112 (1 109 118.
33. Pratt CM, Moye LA (1995). The cardiac arrhythmia suppression trial. Casting suppression in a different light. Circulation 91 (1 245 247.
34. Ravingerova T, Tribulova N, Slezak J, Curtis MJ (1995). Brief, intermediate and prolonged ischemia in the isolated crystalloid perfused rat heart: relationship between susceptibility to arrhythmias and degree of ultrastructural injury. J Mol Cell Cardiol 27 (9 1937 1951.
35. Ridley PD, Yacoub MH, Curtis MJ (1992). A modified model of global ischaemia: application to the study of syncytial mechanisms of arrhythmogenesis. Cardiovasc Res 26 (4 309 315.
36. 4 in cardiac tissue and its role in infarct extension through leucocyte migration. Cardiovasc Res 22 (2 142 148.
37. Schömig A, Dart AM, Dietz R, Mayer E, Kubler W (1984). Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: locally mediated release. Circ Res 55 (5 689 701. (Pubitemid 15176964)
38. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD et al. (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150 (1 76 85.
39. Smith TW, Cain ME (2006). Sudden cardiac death: epidemiologic and financial worldwide perspective. J Interv Card Electrophysiol 17 (3 199 203.
40. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM et al. (1988). The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 22 (7 447 455.
41. Zurier RB, Weissmann G, Hoffstein S, Kammerman S, Tai HH (1974). Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. J Clin Invest 53 (1 297 309.